Evaluation of Metionac for the Modulation of Metabolic and Endocrine Parameters in Patients With PCOS.

Clinical trial NCT05340634 · COMPLETED

Trial details

NCT number: NCT05340634
Sponsor: Margan Biotech
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Polycystic Ovary Syndrome

Start date: 2020-04-20
Primary completion: 2022-02-02
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.